Abstract

The building blocks fac-[(99m)Tc{kappa(3)-HB(tim(Me))(3)}(CO)(3)] and fac-[(99m)Tc{kappa(3)-R(mu-H)B(tim(Me))(2)}(CO)(3)] [R is H (4a), Ph (5a); tim(Me) is 2-mercapto-1-methylimidazolyl] were obtained almost quantitatively by reacting fac-[(99m)Tc(CO)(3)(H(2)O)(3)](+) with the corresponding scorpionate. These compounds cross the intact blood-brain barrier in mice, with significant retention in the case of 4a and 5a. Using 4a as the lead structure, we have synthesized the functionalized complexes fac-[M{kappa(3)-H(mu-H)B(tim(Bu-pip))(2)}(CO)(3)] [M is Re (8), (99m)Tc (8a); tim(Bu-pip) is methyl[4-((2-methoxyphenyl)-1-piperazinyl)butyl](2-mercapto-1-methylimidazol-5-yl)methanamide] and fac-[M{kappa (3)-H(mu-H)B(tim(Me))(tim(Bu-pip))}(CO)(3)] [M is Re (9), (99m)Tc (9a)] and evaluated their potential as radioactive probes for the targeting of brain 5-HT(1A) serotonergic receptors. The Re complexes exhibit excellent affinity [IC(50)=0.172 +/- 0.003 nM (8); IC(50)=0.65 +/- 0.01 nM (9)] for the 5-HT(1A) receptor. The radioactive congeners ((99m)Tc) have shown an initial brain uptake of 1.38 +/- 0.46%ID g(-1) (8a) and 0.43 +/- 0.12%ID g(-1) (9a), but suffer from a relatively fast washout.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.